Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C061388 |
3-aminopropylphosphinic acid |
3-aminopropylphosphinic acid binds to and results in increased activity of [GABBR1 protein binds to GABBR2 protein] | affects binding|increases activity | 15627515
|
C061388 |
3-aminopropylphosphinic acid |
Calcium promotes the reaction [3-aminopropylphosphinic acid binds to and results in increased activity of [GABBR1 protein binds to GABBR2 protein]] | affects binding|increases activity|increases reaction | 15627515
|
C061388 |
3-aminopropylphosphinic acid |
CGP 7930 promotes the reaction [3-aminopropylphosphinic acid binds to and results in increased activity of [GABBR1 protein binds to GABBR2 protein]] | affects binding|increases activity|increases reaction | 15627515
|
D005680 |
gamma-Aminobutyric Acid |
Calcium promotes the reaction [CGP 55845A inhibits the reaction [gamma-Aminobutyric Acid binds to and results in increased activity of [GABBR1 protein binds to GABBR2 protein]]] | affects binding|decreases reaction|increases activity|increases reaction | 15627515
|
D005680 |
gamma-Aminobutyric Acid |
Calcium promotes the reaction [gamma-Aminobutyric Acid binds to and results in increased activity of [GABBR1 protein binds to GABBR2 protein]] | affects binding|increases activity|increases reaction | 15627515
|
D005680 |
gamma-Aminobutyric Acid |
CGP 55845A inhibits the reaction [gamma-Aminobutyric Acid binds to and results in increased activity of [GABBR1 protein binds to GABBR2 protein]] | affects binding|decreases reaction|increases activity | 15627515
|
D005680 |
gamma-Aminobutyric Acid |
CGP 7930 promotes the reaction [gamma-Aminobutyric Acid binds to and results in increased activity of [GABBR1 protein binds to GABBR2 protein]] | affects binding|increases activity|increases reaction | 15627515
|
D005680 |
gamma-Aminobutyric Acid |
Egtazic Acid inhibits the reaction [CGP 7930 promotes the reaction [gamma-Aminobutyric Acid binds to and results in increased activity of [GABBR1 protein binds to GABBR2 protein]]] | affects binding|decreases reaction|increases activity|increases reaction | 15627515
|
D005680 |
gamma-Aminobutyric Acid |
Fendiline inhibits the reaction [CGP 7930 promotes the reaction [gamma-Aminobutyric Acid binds to and results in increased activity of [GABBR1 protein binds to GABBR2 protein]]] | affects binding|decreases reaction|increases activity|increases reaction | 15627515
|
D005680 |
gamma-Aminobutyric Acid |
gamma-Aminobutyric Acid binds to and results in increased activity of [GABBR1 protein binds to GABBR2 protein] | affects binding|increases activity | 15627515
|
D005680 |
gamma-Aminobutyric Acid |
Trifluoperazine inhibits the reaction [CGP 7930 promotes the reaction [gamma-Aminobutyric Acid binds to and results in increased activity of [GABBR1 protein binds to GABBR2 protein]]] | affects binding|decreases reaction|increases activity|increases reaction | 15627515
|
D000643 |
Ammonium Chloride |
Ammonium Chloride affects the expression of GABBR2 mRNA | affects expression | 16483693
|
C006632 |
arsenic trioxide |
arsenic trioxide results in decreased expression of GABBR2 mRNA | decreases expression | 15761015
|
D001418 |
Baclofen |
Baclofen binds to GABBR2 protein | affects binding | 17496723
|
D002118 |
Calcium |
Calcium promotes the reaction [3-aminopropylphosphinic acid binds to and results in increased activity of [GABBR1 protein binds to GABBR2 protein]] | affects binding|increases activity|increases reaction | 15627515
|
D002118 |
Calcium |
Calcium promotes the reaction [CGP 55845A inhibits the reaction [gamma-Aminobutyric Acid binds to and results in increased activity of [GABBR1 protein binds to GABBR2 protein]]] | affects binding|decreases reaction|increases activity|increases reaction | 15627515
|
D002118 |
Calcium |
Calcium promotes the reaction [gamma-Aminobutyric Acid binds to and results in increased activity of [GABBR1 protein binds to GABBR2 protein]] | affects binding|increases activity|increases reaction | 15627515
|
D002251 |
Carbon Tetrachloride |
Carbon Tetrachloride results in increased expression of GABBR2 mRNA | increases expression | 19784758
|
C085075 |
CGP 55845A |
Calcium promotes the reaction [CGP 55845A inhibits the reaction [gamma-Aminobutyric Acid binds to and results in increased activity of [GABBR1 protein binds to GABBR2 protein]]] | affects binding|decreases reaction|increases activity|increases reaction | 15627515
|
C085075 |
CGP 55845A |
CGP 55845A binds to and results in decreased activity of [GABBR1 protein binds to GABBR2 protein] | affects binding|decreases activity | 15627515
|
C085075 |
CGP 55845A |
CGP 55845A inhibits the reaction [gamma-Aminobutyric Acid binds to and results in increased activity of [GABBR1 protein binds to GABBR2 protein]] | affects binding|decreases reaction|increases activity | 15627515
|
C438607 |
CGP 7930 |
CGP 7930 promotes the reaction [3-aminopropylphosphinic acid binds to and results in increased activity of [GABBR1 protein binds to GABBR2 protein]] | affects binding|increases activity|increases reaction | 15627515
|
C438607 |
CGP 7930 |
CGP 7930 promotes the reaction [gamma-Aminobutyric Acid binds to and results in increased activity of [GABBR1 protein binds to GABBR2 protein]] | affects binding|increases activity|increases reaction | 15627515
|
C438607 |
CGP 7930 |
Egtazic Acid inhibits the reaction [CGP 7930 promotes the reaction [gamma-Aminobutyric Acid binds to and results in increased activity of [GABBR1 protein binds to GABBR2 protein]]] | affects binding|decreases reaction|increases activity|increases reaction | 15627515
|
C438607 |
CGP 7930 |
Fendiline inhibits the reaction [CGP 7930 promotes the reaction [gamma-Aminobutyric Acid binds to and results in increased activity of [GABBR1 protein binds to GABBR2 protein]]] | affects binding|decreases reaction|increases activity|increases reaction | 15627515
|
C438607 |
CGP 7930 |
Trifluoperazine inhibits the reaction [CGP 7930 promotes the reaction [gamma-Aminobutyric Acid binds to and results in increased activity of [GABBR1 protein binds to GABBR2 protein]]] | affects binding|decreases reaction|increases activity|increases reaction | 15627515
|
D004533 |
Egtazic Acid |
Egtazic Acid inhibits the reaction [CGP 7930 promotes the reaction [gamma-Aminobutyric Acid binds to and results in increased activity of [GABBR1 protein binds to GABBR2 protein]]] | affects binding|decreases reaction|increases activity|increases reaction | 15627515
|
D004958 |
Estradiol |
Estradiol affects the expression of GABBR2 mRNA | affects expression | 14699072
|
D004958 |
Estradiol |
[Estradiol co-treated with Tetrachlorodibenzodioxin] results in increased expression of GABBR2 mRNA | affects cotreatment|increases expression | 19619570
|
D004958 |
Estradiol |
Estradiol results in increased expression of GABBR2 mRNA | increases expression | 19619570
|
D005275 |
Fendiline |
Fendiline inhibits the reaction [CGP 7930 promotes the reaction [gamma-Aminobutyric Acid binds to and results in increased activity of [GABBR1 protein binds to GABBR2 protein]]] | affects binding|decreases reaction|increases activity|increases reaction | 15627515
|
D008743 |
Methyl Parathion |
Methyl Parathion results in increased expression of GABBR2 mRNA | increases expression | 19784758
|
D010278 |
Parathion |
Parathion results in increased expression of GABBR2 mRNA | increases expression | 19784758
|
D013749 |
Tetrachlorodibenzodioxin |
[Estradiol co-treated with Tetrachlorodibenzodioxin] results in increased expression of GABBR2 mRNA | affects cotreatment|increases expression | 19619570
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in increased expression of GABBR2 mRNA | increases expression | 16704738 19619570
|
C402769 |
tipifarnib |
tipifarnib results in increased expression of GABBR2 mRNA | increases expression | 16403772
|
D014268 |
Trifluoperazine |
Trifluoperazine inhibits the reaction [CGP 7930 promotes the reaction [gamma-Aminobutyric Acid binds to and results in increased activity of [GABBR1 protein binds to GABBR2 protein]]] | affects binding|decreases reaction|increases activity|increases reaction | 15627515
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
2.84 | 15322242 11752688 14514962 |
MESH:D000138 |
Acidosis |
|
Ammonium Chloride |
3.55 | 18287403 |
MESH:D000230 |
Adenocarcinoma |
|
arsenic trioxide |
4.38 | 11798837 19825857 |
MESH:D000230 |
Adenocarcinoma |
|
Estradiol |
4.38 | 11473722 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
3.37 | 16835633 |
MESH:D000382 |
Agricultural Workers' Diseases |
|
Parathion |
4.99 | 17119214 11874814 |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
2.93 | 11748828 |
MESH:D000787 |
Angina Pectoris |
|
Fendiline |
6.90 | 12088766 |
MESH:D001321 |
Autistic Disorder |
marker/mechanism |
|
| 19002745 |
MESH:D001778 |
Blood Coagulation Disorders |
|
arsenic trioxide |
8.90 | 16206674 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
8.90 | 12125929 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
3.79 | 15340226 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
2.75 | 15746008 |
MESH:D001943 |
Breast Neoplasms |
|
Estradiol |
2.03 | 12948864 16675129 17289903 19861407 17261762 18497071 14630087 17018787 |
MESH:D001943 |
Breast Neoplasms |
|
Parathion |
2.03 | 12762645 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
2.03 | 20435547 |
MESH:D002051 |
Burkitt Lymphoma |
|
arsenic trioxide |
4.31 | 11589617 |
MESH:D002181 |
Candidiasis, Vulvovaginal |
|
Estradiol |
4.45 | 16111702 |
MESH:D002252 |
Carbon Tetrachloride Poisoning |
|
Carbon Tetrachloride |
3.77 | 16097048 15721981 3786805 15673190 16050911 15700767 16192424 16227642 16011737 18705752 16124888 10355542 |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
2.78 | 16835633 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
arsenic trioxide |
4.58 | 15073043 16217749 11135700 14691202 15553829 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Carbon Tetrachloride |
4.58 | 18788625 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Estradiol |
4.58 | 16924424 |
MESH:D002291 |
Carcinoma, Papillary |
|
arsenic trioxide |
4.87 | 19014326 |
MESH:D018288 |
Carcinoma, Small Cell |
|
arsenic trioxide |
4.10 | 12490120 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
2.35 | 18670907 16120746 18850075 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Estradiol |
2.76 | 18566989 |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
3.14 | 16835633 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
2.09 | 15668235 8697196 12621046 15340226 16354765 |
MESH:D015179 |
Colorectal Neoplasms |
|
arsenic trioxide |
1.86 | 20501625 |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
3.04 | 17141729 14669216 |
MESH:D023903 |
Coronary Restenosis |
|
arsenic trioxide |
4.17 | 12609071 |
MESH:D019465 |
Craniofacial Abnormalities |
|
arsenic trioxide |
2.46 | 10525206 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
2.46 | 10048152 20055451 15322242 |
MESH:D016757 |
Death, Sudden, Cardiac |
|
arsenic trioxide |
4.08 | 15213294 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
1.66 | 17107852 |
MESH:D003928 |
Diabetic Nephropathies |
|
Estradiol |
3.39 | 19279558 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Carbon Tetrachloride |
3.70 | 6884620 19336974 3786805 11566570 15027814 16177239 3732212 7440962 10092053 19085960 6623471 16227642 7120509 21278145 15998439 9327722 7179309 15968718 4309450 17522070 2869522 10915739 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
3.70 | 20420201 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
2.74 | 11462148 |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
2.36 | 11000095 12711302 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
3.90 | 16714409 15322242 18230668 |
MESH:D016889 |
Endometrial Neoplasms |
|
Estradiol |
2.97 | 18566989 19148513 11473722 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
3.00 | 10568697 9294722 |
MESH:D004938 |
Esophageal Neoplasms |
|
arsenic trioxide |
2.30 | 12903497 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
3.00 | 11564622 |
MESH:D005234 |
Fatty Liver |
|
arsenic trioxide |
7.81 | 15073043 |
MESH:D005234 |
Fatty Liver |
|
Carbon Tetrachloride |
7.81 | 12631006 16239168 15959796 61145 12795759 19224547 16045604 17595544 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
3.44 | 11858732 |
MESH:D005355 |
Fibrosis |
|
Carbon Tetrachloride |
8.55 | 18705752 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
8.55 | 20067830 |
MESH:D005706 |
Gallbladder Neoplasms |
|
arsenic trioxide |
4.24 | 16904648 |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
4.59 | 10696789 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
2.32 | 11294989 10048152 |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
3.32 | 11000095 |
MESH:D006505 |
Hepatitis |
|
Carbon Tetrachloride |
3.58 | 19900420 19110552 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
2.88 | 16120746 15340226 12621046 |
MESH:D006558 |
Herpes Genitalis |
|
Estradiol |
5.03 | 15709030 |
MESH:D019584 |
Hot Flashes |
|
Estradiol |
3.75 | 17088409 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
4.05 | 8697196 16354765 15340226 18606429 16959395 |
MESH:D006932 |
Hyperbilirubinemia |
|
Carbon Tetrachloride |
4.52 | 16899240 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
1.90 | 18670907 18850075 |
MESH:D006975 |
Hypertension, Portal |
|
Carbon Tetrachloride |
4.07 | 15338365 |
MESH:D007248 |
Infertility, Male |
|
Parathion |
4.47 | 16029889 |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
1.84 | 12878042 12200463 |
MESH:D007333 |
Insulin Resistance |
|
Estradiol |
2.95 | 16627594 16393666 |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
3.32 | 16580747 |
MESH:D007674 |
Kidney Diseases |
|
Estradiol |
2.57 | 15618244 |
MESH:D007680 |
Kidney Neoplasms |
|
Estradiol |
2.96 | 15610895 |
MESH:D007683 |
Kidney Tubular Necrosis, Acute |
|
Calcium |
5.05 | 16316344 |
MESH:D007938 |
Leukemia |
|
arsenic trioxide |
2.82 | 15070760 |
MESH:D015459 |
Leukemia-Lymphoma, Adult T-Cell |
|
arsenic trioxide |
3.78 | 12560223 17077332 |
MESH:D007948 |
Leukemia, Monocytic, Acute |
|
arsenic trioxide |
4.30 | 16972261 |
MESH:D015464 |
Leukemia, Myelogenous, Chronic, BCR-ABL Positive |
|
arsenic trioxide |
3.41 | 14633726 |
MESH:D007951 |
Leukemia, Myeloid |
|
arsenic trioxide |
3.74 | 19077051 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
arsenic trioxide |
2.13 | 17050201 16467208 20471514 19850784 16968895 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
arsenic trioxide |
3.20 | 12679006 16112521 16823087 16330433 9834237 16331271 17712046 15336539 19642359 17107899 12712474 15748426 17649720 11161223 11468182 17869043 19075265 17217047 16891316 16966277 15213294 15622746 19035177 19225113 12018890 |
MESH:D015458 |
Leukemia, T-Cell |
|
arsenic trioxide |
4.34 | 16882451 |
MESH:D008103 |
Liver Cirrhosis |
|
Carbon Tetrachloride |
2.80 | 11903743 11408273 16943688 21278145 17334410 17174718 16221502 16239168 17157831 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Carbon Tetrachloride |
3.42 | 12741479 14512876 12632514 15925388 16027843 14620537 12586293 17698563 18279442 17714472 12898905 17805973 18205269 18251166 17557913 18395914 18429990 12649538 15996030 15931870 12546737 18006644 10355542 15730626 17721639 15052691 18418968 14748882 17565644 18472332 17631135 18277467 16192424 18412020 12632512 12666154 18705752 14716496 15057751 12389079 16116963 16015684 14716833 18210741 17944888 17761835 17525996 16097048 18317297 18376398 12667390 15338365 17976157 16638106 15362042 18472094 17900296 16248980 18187930 17869086 18339082 17481882 18420326 16136751 18166357 17823541 12609069 18054572 15959796 15818738 16033810 15370692 17766677 17922224 18481824 15673190 18395095 17708605 15123356 12445418 18263696 12445421 20821823 11481614 17640975 13678700 16011737 15876570 18156304 12958196 14724832 15650968 15893842 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Estradiol |
3.42 | 14716833 14659978 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
3.42 | 12878042 |
MESH:D008107 |
Liver Diseases |
|
Carbon Tetrachloride |
2.08 | 16246199 15830285 16964402 17285989 15720792 |
MESH:D017093 |
Liver Failure |
|
Carbon Tetrachloride |
4.15 | 15123358 |
MESH:D017114 |
Liver Failure, Acute |
|
Carbon Tetrachloride |
3.67 | 16899240 14706259 |
MESH:D008113 |
Liver Neoplasms |
|
arsenic trioxide |
7.36 | 14682389 |
MESH:D008113 |
Liver Neoplasms |
|
Carbon Tetrachloride |
7.36 | 19294768 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
7.36 | 16984957 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
arsenic trioxide |
9.73 | 20377131 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Carbon Tetrachloride |
9.73 | 15583823 12014681 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
9.73 | 12151625 |
MESH:D008133 |
Long QT Syndrome |
|
arsenic trioxide |
3.33 | 15213294 |
MESH:D008175 |
Lung Neoplasms |
|
arsenic trioxide |
3.60 | 19825857 11798837 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
3.60 | 11884234 19555203 |
MESH:D008175 |
Lung Neoplasms |
|
tipifarnib |
3.60 | 16885199 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Estradiol |
6.55 | 11807958 17203775 11408345 16891317 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
tipifarnib |
6.55 | 16648579 |
MESH:D020149 |
Manganese Poisoning |
|
Estradiol |
4.48 | 19453300 |
MESH:D009101 |
Multiple Myeloma |
|
arsenic trioxide |
3.09 | 15949261 19417148 14977855 11468182 19549372 |
MESH:D009182 |
Mycosis Fungoides |
|
arsenic trioxide |
4.67 | 18349030 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
arsenic trioxide |
3.13 | 16105982 16882451 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
3.00 | 12213967 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
Estradiol |
3.26 | 16810080 |
MESH:D009361 |
Neoplasm Invasiveness |
|
arsenic trioxide |
3.94 | 16624393 |
MESH:D009389 |
Neovascularization, Pathologic |
|
Estradiol |
3.72 | 17289903 |
MESH:D009421 |
Nervous System Malformations |
|
Estradiol |
9.41 | 16427766 11399458 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
9.41 | 14600291 |
MESH:D009436 |
Neural Tube Defects |
|
arsenic trioxide |
3.10 | 10525206 |
MESH:D020258 |
Neurotoxicity Syndromes |
|
Methyl Parathion |
4.83 | 19784758 |
MESH:D010024 |
Osteoporosis |
|
Calcium |
3.77 | 17882678 |
MESH:D010051 |
Ovarian Neoplasms |
|
arsenic trioxide |
4.81 | 19769630 16624393 12452020 |
MESH:D010051 |
Ovarian Neoplasms |
|
Estradiol |
4.81 | 19401270 |
MESH:D010190 |
Pancreatic Neoplasms |
|
arsenic trioxide |
2.52 | 15580305 |
MESH:D010235 |
Paraganglioma |
|
arsenic trioxide |
4.14 | 19927285 |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
4.25 | 12520081 |
MESH:D011041 |
Poisoning |
|
Methyl Parathion |
5.02 | 17603234 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
3.54 | 18163543 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
3.18 | 11222880 11896295 11399792 11118676 |
MESH:D019048 |
Prostatic Intraepithelial Neoplasia |
|
Estradiol |
3.87 | 20887781 |
MESH:D011471 |
Prostatic Neoplasms |
|
arsenic trioxide |
3.23 | 19131511 |
MESH:D011471 |
Prostatic Neoplasms |
|
Estradiol |
3.23 | 16740699 |
MESH:D012135 |
Respiratory Sounds |
|
Parathion |
5.28 | 11874814 17119214 |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
3.82 | 18990726 |
MESH:D012140 |
Respiratory Tract Diseases |
|
Parathion |
5.55 | 17119214 |
MESH:D012512 |
Sarcoma, Ewing's |
|
arsenic trioxide |
3.94 | 16646077 |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
2.03 | 16192470 |
MESH:D013274 |
Stomach Neoplasms |
|
arsenic trioxide |
1.86 | 17007042 |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
3.90 | 12697716 |
MESH:D013964 |
Thyroid Neoplasms |
|
arsenic trioxide |
3.07 | 19014326 |
MESH:D013978 |
Tibial Fractures |
|
Estradiol |
4.69 | 19048282 |
OMIM:188890 |
TOBACCO ADDICTION, SUSCEPTIBILITY TO |
marker/mechanism |
|
| |
MESH:D016171 |
Torsades de Pointes |
|
arsenic trioxide |
3.95 | 15213294 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
arsenic trioxide |
2.47 | 12973940 20435036 12845720 11780464 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
4.59 | 12125929 |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
4.25 | 15886252 |